Background It is unknown whether either the angiotensin-II–receptor blocker irbesartan or the
calcium-channel blocker amlodipine slows the progression of nephropathy in patients with …

From 1969 to 1979, 169 patients with two or more renal angiograms for renovascular disease
(85 atherosclerotic, 75 fibrous, 9 atherosclerotic and fibrous) were reviewed in an attempt …

Elevated arterial pressure is a major risk factor for progression to ESRD in diabetic nephropathy.
However, the component of arterial pressure and level of BP control for optimal renal …

Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial.
Background A clinical trial of cyclosporine in patients with steroid-resistant membranous …

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental
glomerulosclerosis. Background A clinical trial of cyclosporine in patients with steroid-resistant focal …

Pyridoxamine dihydrochloride (Pyridorin, NephroGenex) inhibits formation of advanced
glycation end products and scavenges reactive oxygen species and toxic carbonyls, but whether …

We reviewed our experience with surgical revascularization (SR) for renal artery disease (RAD)
in 361 patients from 1975 through 1984 to illustrate the evolving role of SR in the …

BACKGROUND: Sulodexide, a heterogenous group of sulfated glycosaminoglycans, includes
low-molecular-weight heparin (∼80% ± 8%), high-molecular-weight heparin (∼5% ± 3%)…

The purpose of this study was to determine the usefulness of a random urine specimen
protein to creatinine (P/C) ratio in predicting 24-hour urine protein excretion (24 UP) in type 1 …

Objective: To determine whether plasmapheresis increases the risk for infection in
immunosuppressed patients. Design: Randomized, controlled trial. Setting: Multicenter. Patients: …